Welcome to
Generation Liberation
Just like you, more and more people with Tyrosinemia Type 1 (HT-1), and their caregivers, are discovering the possibility of greater independence when it comes to their nitisinone medication. NITYR (nitisinone) Tablets are designed to put your needs first, both now and in the future.
Product
NITYR is Here for You, for Life
Designed for convenience, NITYR gives patients and their caregivers one less thing to worry about. NITYR liberates patients from the start, with the convenience, flexibility and freedom that has enabled 100% of the patients who have transitioned to NITYR to not voluntarily return to Orfadin** (nitisinone). 1
- Very small and discreet2
- Baby aspirin-sized: 20% the volume of a single Orfadin** (nitisinone) capsule2
- NITYR is suitable for all age groups. It can be given as a suspension, crushed and mixed with applesauce, or swallowed whole
- No refrigeration restrictions
- Can be taken with or without food3
- Makes NITYR easy to take on the go
- Bioequivalent to Orfadin** (nitisinone) capsules4
- Same efficacy, same safety and same side effects as Orfadin4
Support
We know that life-changing treatments need a support system which is tailored to the unique challenges you might be facing. That’s why we created Cycle Vita, our dedicated hub support program, which delivers individualized product support* at every step. Including:
- Financial Assistance
- Patient Nutrition Program*
- Quick Start program*
+1 (888) 360-8482
Alina's Story
When Alina’s parents learned she had Tyrosinemia Type 1 (HT-1), they were understandably concerned. But, with NITYR, they have a safe, proven medicine that allows Alina to live life to the fullest…
Ethan's Story
Five-year-old Ethan has Tyrosinemia Type 1 (HT-1). Like any family that has a child with this ultra rare condition, the family have found Ethan’s diet and medication regime very demanding…
Jamie's Story
A few years ago, Jamie was introduced to NITYR by her doctor who explained that NITYR contained the same active ingredient, nitisinone (NTBC), as her current medication…
* Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at +1 (888) 360-8482.
** Orfadin is a registered trademark, licensed by Swedish Orphan Biovitrum AB (publ) and is marketed by Sobi, Inc.
References
1. Data on file: REF-00005. Data represents fully enrolled, insured NITYR patients in the US from August 2017 to February 2021.
2. Data on file: REF-00041.
3. Nityr (Nitisinone) Tablets. Prescribing Information. Cycle Pharmaceuticals Ltd.
4. Data on file REF-00047